Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

NCT00083668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone ER

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.